Picture EBD Group BioPharm America 2019 Boston September 600x60px
Collaboration › Details

Fujifilm–Zyme Communications: public relations, 201901 service existent for Fujifilm Irvine Scientific by Zyme


Period Period 2019-01-02
Organisations Partner, 1st Fujifilm Irvine Scientific Inc. (FISI)
  Group Fujifilm (Group)
  Partner, 2nd Zyme Communications Ltd.
Products Product public relations / investor relations / marcom (services)
  Product 2 cell culture media
Person Person Cuddon, Lorna (Zyme Communications 201007– Managing Director + Founder before College Hill Life Sciences)

Fujifilm Irvine Scientific, Inc.. (1/2/19). "Press Release: Accelerating the Growth of the Cell Culture Media Business. Leading Cell Culture Media Company Changes Name to »Fujifilm Irvine Scientific, Inc.«".

FUJIFILM Irvine Scientific, Inc. (President: Yutaka Yamaguchi, FISI), a US subsidiary of FUJIFILM Corporation (President: Kenji Sukeno), and a leading company in cell culture media, today announced that on January 1, 2019 in the United States, the company changed its name from Irvine Scientific Sales Company, Inc.

The new company name combines the “FUJIFILM” brand, which is recognized worldwide as a global company, together with the “Irvine Scientific” brand, which has been established as a leading company for cell culture media. Under this new company name, FISI will further expand its cell culture media business and accelerate the growth of Fujifilm Group’s bio-medical field through synergies and collaborations.

FISI provides a wide range of products including cell culture media for biopharmaceutical production, in vitro fertilization, and cell therapy. The company can develop the optimal custom culture medium to meet the customers’ needs by utilizing its extensive capabilities in quality control, research and development, as well as its proven track record and know-how accumulated over the years.

FISI will accelerate the development of high-performance and highly competitive cell culture media solutions by combining its advanced development and manufacturing capabilities with FUJIFILM Group’s bio-related technologies. Also, it will further expand the media business by leveraging FUJIFILM Group’s collective capabilities in the bio-medical field.

By developing and providing high-performance cell culture media for biopharmaceutical production, in vitro fertilization, and cell therapy, FISI will contribute to advancing biopharmaceutical development, improving the quality of assisted reproductive technologies, and promoting the commercialization of regenerative medicine.

1. New company name: FUJIFILM Irvine Scientific, Inc.

2. Date of change: January 1, 2019 in the United States


Outline of FUJIFILM Irvine Scientific, Inc.

Company Name
FUJIFILM Irvine Scientific, Inc.

Santa Ana, California, U.S.A.

Year of incorporation

Yutaka Yamaguchi

FUJIFILM Holdings America Corporation (100%)

For inquiries on information in this media release, contact:

Media Contacts:
FUJIFILM Corporation
Corporate Communications Division
TEL: +81-3-6271-2000

FUJIFILM Irvine Scientific, Inc.
Phone: +1 949-261-7800 x145

Lorna Cuddon, Zyme Communications
Phone: +44 (0)7811996942

Record changed: 2019-03-14


Picture [LSUS] – The Business Web Portal 600x60px

More documents for Fujifilm (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top